Primary Biliary Cirrhosis in A Patient with Turner Syndrome by Piotr Milkiewicz, Jenny Heathcote

“…The patient did not respond to the medical treatment and was referred for liver transplant assessment. The present case may support the importance of X chromosome genes in the development of genetic predisposition to PBC, and emphasizes the necessity for a systematic study of the prevalence of PBC in patients with Turner syndrome.…”
Get full text

Time to Make the Change from ‘Primary Biliary Cirrhosis’ to ‘Primary Biliary Cholangitis’ by Angela C Cheung, Aldo Montano-Loza, Mark Swain, Catherine Vincent, Eberhard Renner, Morris Sherman, Harry LA Janssen, Andrew L Mason

Get full text

Long-Term Suitability of Left Gastric Artery Inflow for Arterial Perfusion of Living Donor Right Lobe Grafts by Judyta A. Lipinska, Johnny Wang, Joseph N. Carey, Aaron A. Ahearn, Yuri S. Genyk

“…Poorer than expected, living donor liver transplant outcomes are observed after recipient graft artery thrombosis. …”
Get full text

Hepatocellular Carcinoma to the Right Ventricle by George R. Marzouka, Apurva Badheka, Alexis P. Rodriguez, Sandra V. Chaparro

“…The patient had undergone two prior liver transplantations. He presented to the hospital complaining of worsening lower extremity edema. …”
Get full text

Cardiac Arrest and Gastrointestinal Bleeding: A Case of Medical Heuristics by Tokunbo Ajayi, Jerome Okudo

“…He was subsequently transferred to the liver transplant center on discovery that he was in fulminant hepatic failure and died two days later in spite of aggressive medical treatment.…”
Get full text

Clinical Application of Partial Splenic Embolization by Yong-Song Guan, Ying Hu

“…It is also performed to exclude splenic artery aneurysms from the parent vessel lumen and prevent aneurysm rupture, to treat splenic artery steal syndrome and improve liver perfusion in liver transplant recipients, and to administer targeted treatment to areas of neoplastic disease in the splenic parenchyma. …”
Get full text

Comment on “Total Pancreatectomy With Islet Autotransplantation as an Alternative to High-Risk Pancreatojejunostomy After Pancreaticoduodenectomy: A Prospective Randomized Trial”... by Leo Buhler, MD, Ty Dunn, MD, Ugo Boggi, MD, Charles Vollmer, MD, Jens Werner, MD, Christos Dervenis, MD, Giovanni Marchegiani, MD, Shailesh V. Shrikhande, MD, Igor Khatkov, MD, Abraham Fingerhut, MD

Get full text

Fungal Infections: Their Diagnosis and Treatment in Transplant Recipients by David H. Van Thiel, Magdalena George, Christopher M. Moore

“…The indications for the use of currently available antifungal agents, their adverse effects, drug interactions, ease of dosing, and applicability in patients with preexisting disease states, and especially in liver transplant recipients, are presented in this paper.…”
Get full text

Neglected Fournier’s Gangrene Caused by Acinetobacter baumannii: A Rare Case Report by Arif Emre, Mehmet Sertkaya, Sami Akbulut, Yakup Duman, Ilhami Taner Kale

Get full text

Regulatory T Cells in Autoimmune and Viral Chronic Hepatitis by Pascal Lapierre, Alain Lamarre

“…With the recent advent of monoclonal antibodies able to target regulatory T cells (daclizumab) and improve immune responses and several ongoing clinical trials analysing the impact of regulatory T cell infusion on autoimmune liver disease or liver transplant tolerance, modulation of immunological tolerance through CD4+ regulatory T cells could be a key element of future immunotherapies for several liver diseases allowing restoring the balance between proper immune responses and tolerance.…”
Get full text

Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients by Radhika Zopey, Irawan Susanto, Igor Barjaktarevic, Tisha Wang

“…Although the mechanisms for this phenomenon remain unclear, it is important to be vigilant of this phenomenon as it may change the patient's overall treatment plan, especially in regard to appropriateness and timing of liver transplant.…”
Get full text

Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024Keypoints by Bastian Engel, David N. Assis, Mamatha Bhat, Jan Clusmann, Joost PH. Drenth, Alessio Gerussi, María-Carlota Londoño, Ye Htun Oo, Ida Schregel, Marcial Sebode, Richard Taubert

“…Chronic autoimmune responses against the liver can cause hepatic and extrahepatic symptoms, decreased quality of life and reduced liver transplant-free survival if inadequately treated. …”
Get full text

Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease by Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Stefan Chiriac, Cristina M. Muzica, Catalin Victor Sfarti, Tudor Cuciureanu, Laura Huiban, Carol Stanciu, Anca Trifan

“…The proportion of patients with liver cirrhosis and those with hepatocellular carcinoma due to nonalcoholic liver disease on the liver transplant waiting list has increased in the last years. …”
Get full text

Elevated Incidence of Fractures in Solid-Organ Transplant Recipients on Glucocorticoid-Sparing Immunosuppressive Regimens by B. J. Edwards, A. Desai, J. Tsai, H. Du, G. R. Edwards, A. D. Bunta, A. Hahr, M. Abecassis, S. Sprague

“…The estimated relative risk of fracture was nearly seventeen-times higher in male liver transplant recipients ages 45–64 years compared with the general male population, and comparable to fracture rates on conventional immunosuppressant regimens. …”
Get full text

Ultrasound-Guided Genicular Nerve Thermal Radiofrequency Ablation for Chronic Knee Pain by Joshua Wong, Nicholas Bremer, Paul D. Weyker, Christopher A. J. Webb

Get full text

Nonalcoholic Fatty Liver Disease in Patients Investigated for Elevated Liver Enzymes by Krikor Kichian, Ross Mclean, Leah M Gramlich, Robert J Bailey, Vincent G Bain

“…These patients were seen between 1996 and 2000 in gastroenterology and hepatology clinics in two community hospitals and one regional liver transplant centre in Edmonton, Alberta. NAFLD was associated with a spectrum of changes in the liver ranging from mild steatosis to more significant steatosis with inflammation and fibrosis. …”
Get full text

Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance by M. Ghabril, R. C. Dickson, M. Krishna, R. Lloyd, J. Aranda-Michel, A. Keaveny, R. Satyanarayana, H. Bonatti

“…Twenty five patients with undetectable serum HCV on Interferon/Ribavirin therapy for HCV recurrence post liver transplant (LT) were studied. All had biopsies at 4 months post LT (baseline) and follow up with HCV ISH analysis performed. …”
Get full text

A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients by Ulf Neumann, Didier Samuel, Pavel Trunečka, Jean Gugenheim, Giorgio Enrico Gerunda, Styrbjörn Friman

“…Allograft reinfection with hepatitis C virus (HCV) occurs universally in liver transplant recipients. Corticosteroids can contribute to HCV recurrence. …”
Get full text

Attitudes towards transjugular intrahepatic portosystemic shunt (TIPS) in Australia: a national survey of TIPS centres by Jacob George, Avik Majumdar, Golo Ahlenstiel, Stuart K Roberts, Scott Read, Eric Kalo

Get full text

Short-term costs of alcohol-associated hepatitis care in different clinical settings by Chi Mai Nguyen, Jing Su, Yang Li, Ryan Healey, Shihui Jiang, Jiangqiong Li, Naga Chalasani, Samer Gawrieh, Suthat Liangpunsakul, Wanzhu Tu

“…Significant cost drivers in IP included comorbidities associated with moderate-to-severe liver disease, metabolic syndrome, liver transplant, and mortality during the 30-day follow-up period. …”
Get full text